In the last trading session, 2.42 million shares of the Oncology Institute Inc (NASDAQ:TOI) were traded, and its beta was 0.12. Most recently the company’s share price was $0.55, and it changed around $0.06 or 13.40% from the last close, which brings the market valuation of the company to $41.56M. TOI currently trades at a discount to its 52-week high of $2.45, offering almost -345.45% off that amount. The share price’s 52-week low was $0.13, which indicates that the current value has risen by an impressive 76.36% since then. We note from Oncology Institute Inc’s average daily trading volume that its 10-day average is 0.95 million shares, with the 3-month average coming to 1.91 million.
Oncology Institute Inc stock received a consensus recommendation rating of Overweight, based on a mean score of 1.00. If we narrow it down even further, the data shows that 0 out of 1 analysts rate the stock as a Sell; another 1 rate it as Overweight. Among the rest, 0 recommended TOI as a Hold, whereas 0 deemed it a Buy, and 0 rated it as Underweight. Oncology Institute Inc is expected to report earnings per share of 0 for the current quarter.
Oncology Institute Inc (NASDAQ:TOI) trade information
Instantly TOI has showed a green trend with a performance of 13.40% at the end of last trading. The performance over the last five days has remained in the green territory. The rise to weekly highs of 0.6183 on recent trading dayincreased the stock’s daily price by 11.05%. The company’s shares are currently up 77.99% year-to-date, but still up 82.30% over the last five days. On the other hand, Oncology Institute Inc (NASDAQ:TOI) is 179.47% up in the 30-day period. We can see from the shorts that 0.25 million shares have been sold at a short interest cover period of 3.38 day(s).
The consensus price target as assigned by Wall Street analysts is $8, which translates to bulls needing to increase their stock price by 93.12% from its current value. Analyst projections state that TOI is forecast to be at a low of $6 and a high of $10.
Looking at the company’s year-over-year earnings, the past five years showed a negative earnings growth rate of -879.48%.
TOI Dividends
Oncology Institute Inc’s next quarterly earnings report is expected to be released in February.
Oncology Institute Inc (NASDAQ:TOI)’s Major holders
Upon looking at major shareholders, it appears that insiders hold 19.56% of Oncology Institute Inc shares, and 47.59% of them are in the hands of institutional investors. The stock currently has a share float of 59.16%. Oncology Institute Inc stock is held by 45.0 institutions, with FMR LLC being the largest institutional investor. By 2024-06-30, it held 6.4005% of the shares, which is about 4.75 million shares worth $2.19 million.
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), with 4.5263% or 3.36 million shares worth $1.55 million as of 2024-06-30, holds the second largest percentage of outstanding shares.
Vanguard Total Stock Market Index Fund and Vanguard Extended Market Index Fund were the top two Mutual Funds as of Sep 30, 2024 . The former held 1.27 shares worth $0.7 million, making up 1.69% of all outstanding shares. On the other hand, Vanguard Extended Market Index Fund held roughly 422.98 shares worth around $0.23 million, which represents about 0.56% of the total shares outstanding.
